/PRNewswire/ Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer.
EQS-News: Andera Partners / Key word(s): Financing Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches 26.01.2023 / 13:10 CET/CEST The issuer is solely responsible for th.
2021 was a BIG year for European VC and even surpassed what we experienced in 2020. According to the most recent Atomico Report, European startups raised $120bn in funding this year which is almost…